Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephen M Stahl

Showing results (1-10 of 267) with videos related to

Pageof 27
Sort By:
CNS Spectrums|February 23, 2016
Mechanism of action of brexpiprazole: comparison with aripiprazoleStephen M Stahl
CNS Spectrums|August 10, 2016
Mechanism of action of pimavanserin in Parkinson's disease psychosis: targeting serotonin 5HT2A and 5HT2C receptorsStephen M Stahl
The Journal of Clinical Psychiatry|April 29, 2003
Neurotransmission of cognition, part 3. Mechanism of action of selective NRIs: both dopamine and norepinephrine increase in prefrontal cortexStephen M Stahl
CNS Spectrums|February 8, 2017
Psychiatric Pharmacogenomics: How to Integrate into Clinical PracticeStephen M Stahl
The Journal of Clinical Psychiatry|January 28, 2004
Symptoms and circuits, part 3: schizophreniaStephen M Stahl
CNS Spectrums|April 21, 2018
Antagonist treatment is just as effective as replacement therapy for opioid addiction but neither is used often enoughStephen M Stahl
CNS Spectrums|January 30, 2008
Personalized medicine, pharmacogenomics, and the practice of psychiatry: on the threshold of predictive therapeutics in psychopharmacology?Stephen M Stahl
The Journal of Clinical Psychiatry|March 9, 2004
Psychopharmacology of anticonvulsants: do all anticonvulsants have the same mechanism of action?Stephen M Stahl
The Journal of Clinical Psychiatry|May 28, 2004
Anticonvulsants and the relief of chronic pain: pregabalin and gabapentin as alpha(2)delta ligands at voltage-gated calcium channelsStephen M Stahl
The Journal of Clinical Psychiatry|February 19, 2009
Vasomotor symptoms and depression in women, part I. Role of vasomotor symptoms in signaling the onset or relapse of a major depressive episodeStephen M Stahl
Pageof 27

Showing results (1-10 of 267) with videos related to

Sort By:
Pageof 27
CNS Spectrums|February 23, 2016
Mechanism of action of brexpiprazole: comparison with aripiprazoleStephen M Stahl
CNS Spectrums|August 10, 2016
Mechanism of action of pimavanserin in Parkinson's disease psychosis: targeting serotonin 5HT2A and 5HT2C receptorsStephen M Stahl
The Journal of Clinical Psychiatry|April 29, 2003
Neurotransmission of cognition, part 3. Mechanism of action of selective NRIs: both dopamine and norepinephrine increase in prefrontal cortexStephen M Stahl
CNS Spectrums|February 8, 2017
Psychiatric Pharmacogenomics: How to Integrate into Clinical PracticeStephen M Stahl
The Journal of Clinical Psychiatry|January 28, 2004
Symptoms and circuits, part 3: schizophreniaStephen M Stahl
CNS Spectrums|April 21, 2018
Antagonist treatment is just as effective as replacement therapy for opioid addiction but neither is used often enoughStephen M Stahl
CNS Spectrums|January 30, 2008
Personalized medicine, pharmacogenomics, and the practice of psychiatry: on the threshold of predictive therapeutics in psychopharmacology?Stephen M Stahl
The Journal of Clinical Psychiatry|March 9, 2004
Psychopharmacology of anticonvulsants: do all anticonvulsants have the same mechanism of action?Stephen M Stahl
The Journal of Clinical Psychiatry|May 28, 2004
Anticonvulsants and the relief of chronic pain: pregabalin and gabapentin as alpha(2)delta ligands at voltage-gated calcium channelsStephen M Stahl
The Journal of Clinical Psychiatry|February 19, 2009
Vasomotor symptoms and depression in women, part I. Role of vasomotor symptoms in signaling the onset or relapse of a major depressive episodeStephen M Stahl
Pageof 27